In the latest trading session, 0.6 million Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA) shares changed hands as the company’s beta touched 1.36. With the company’s most recent per share price at $0.17 changed hands at -$0.01 or -6.29% at last look, the market valuation stands at $2.62M. SNOA’s current price is a discount, trading about -694.12% off its 52-week high of $1.35. The share price had its 52-week low at $0.12, which suggests the last value was 29.41% up since then. When we look at Sonoma Pharmaceuticals Inc.’s average trading volume, we note the 3-month average coming to 2.35 million.
Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA) trade information
Instantly SNOA was in red as seen in intraday trades today. With action -19.60%, the performance over the past five days has been red. The drop to weekly highs of 0.2083 subtracted -6.29% to the stock’s daily price. The company’s shares are showing year-to-date downside of -7.12%, with the 5-day performance at -19.60% in the red. However, in the 30-day time frame, Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA) is -32.98% down.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sonoma Pharmaceuticals Inc. (SNOA) estimates and forecasts
Data shows that the Sonoma Pharmaceuticals Inc. share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 7.96% over the past 6 months, a 18.35% in annual growth rate that is considerably higher than the industry average of 13.90%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 44.36%.
SNOA Dividends
Sonoma Pharmaceuticals Inc. is expected to release its next quarterly earnings report in July.
